Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test (2022)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROCHA, JULIANA MENDES - FMRP ; ROSSI, GIORDANO NOVAK - FMRP
- Unidade: FMRP
- Subjects: PSICOLOGIA CLÍNICA; ALUCINOGÊNICOS; PERSONALIDADE; TESTES PSICOLÓGICOS
- Keywords: Pfister; Hallucinogens; Ayahuasca
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Abstracts
- Conference titles: Congress of the International Society for the Rorschach and the Projective Methods - ISR 2022
-
ABNT
OSÓRIO, Flávia de Lima et al. Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test. 2022, Anais.. Geneva: ISR, 2022. Disponível em: https://www.asbro.org.br/arquivos/ISR2022_AbstractBook.pdf. Acesso em: 21 maio 2024. -
APA
Osório, F. de L., Rocha, J. M., Rossi, G. N., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2022). Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test. In Abstracts. Geneva: ISR. Recuperado de https://www.asbro.org.br/arquivos/ISR2022_AbstractBook.pdf -
NLM
Osório F de L, Rocha JM, Rossi GN, Bouso JC, Hallak JEC, Santos RG dos. Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test [Internet]. Abstracts. 2022 ;[citado 2024 maio 21 ] Available from: https://www.asbro.org.br/arquivos/ISR2022_AbstractBook.pdf -
Vancouver
Osório F de L, Rocha JM, Rossi GN, Bouso JC, Hallak JEC, Santos RG dos. Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test [Internet]. Abstracts. 2022 ;[citado 2024 maio 21 ] Available from: https://www.asbro.org.br/arquivos/ISR2022_AbstractBook.pdf - Adverse effects after Ayahuasca administration in the clinical setting [Carta]
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies
- The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
- The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: a systematic review of randomized controlled trials
- Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
